Furthermore, we also detected exogenous FAM3A-c-myc distribution in other organs including the heart, liver, and kidney, and the results showed that the FAM3A-c-myc was present in these organs (Supplementary Fig. 4d), suggesting a potential function of recombinant FAM3A in other organs beyond AAA tissues. This evidence concerns the gene MYC and triple-A syndrome.